They found that there is a disruption of P2RX4 function by 5-(3-bromophenyl)-1,3-dihydro-2Hbenzofuro [3,2-e]-1,4-diazepin-2-one diminished prostate cancer growth in vitro and in vivo17. Here, P2RX4 is linked to prostate carcinoma.